Director of Interventional Pulmonology, Pulmonary and Critical Care Medicine Division, University of Cincinnati, Cincinnati, Ohio, USA.
Curr Opin Pulm Med. 2022 Jan 1;28(1):62-67. doi: 10.1097/MCP.0000000000000839.
Pneumothorax is a global health problem. To date, there is still significant variation in the management of pneumothorax. For the past few years, there have been significant developments in the outpatient management of both primary and secondary spontaneous pneumothorax (SSP). We will review the latest evidence for the management of nontraumatic pneumothorax (spontaneous and iatrogenic) to include pneumothorax associated with COVID-19 infection.
Outpatient management of both primary and SSP may be safe and feasible.
Outpatient management of both primary and SSP should be included in treatment options discussion with patients.
气胸是一个全球性的健康问题。迄今为止，气胸的管理仍存在显著差异。在过去的几年中，原发性和继发性自发性气胸（SSP）的门诊管理都取得了重大进展。我们将回顾非创伤性气胸（自发性和医源性）的最新管理证据，包括与 COVID-19 感染相关的气胸。
原发性和 SSP 的门诊管理可能是安全且可行的。
应将原发性和 SSP 的门诊管理纳入与患者的治疗方案讨论中。
